Literature DB >> 17073444

Organization of human interferon gamma-heparin complexes from solution properties and hydrodynamics.

Horacio Perez Sanchez1, Karine Tatarenko, Michael Nigen, Georges Pavlov, Anne Imberty, Hugues Lortat-Jacob, Jose Garcia de la Torre, Christine Ebel.   

Abstract

Heparan sulfate (HS) recognizes a variety of proteins, one of which is the pleiotropic cytokine IFN-gamma, and as such modulates many biological processes. IFN-gamma is a homodimer with a well-defined core and two flexible C-termini that constitute HS binding domains. We show here using molecular modeling that an extended IFN-gamma structure overlaps a HS fragment of 16 disaccharides (16 nm). Since a 21-24-disaccharide HS fragment was experimentally defined as the minimum size that interacts with IFN-gamma [Lortat-Jacob, H., Turnbull, J. E., and Grimaud, J. A. (1995) Biochem. J. 310 (Part 2), 497-505], this raises the question of the complexe organization. We combine analytical ultracentrifugation, size exclusion chromatography, and hydrodynamic bead modeling to characterize the complexes formed in solution with heparin oligosaccharides. For oligosaccharides of 14 and 20 nm, two types of complexes are formed with one IFN-gamma and one or two heparin molecules. Complexes consisting of two IFN-gamma and one or two heparin molecules are present for a fragment of 25 nm and aggregates for a fragment of 35 nm. The complexes are rather compact and can be formed without major conformational changes of the partners. The complex pattern of interaction is related to the size of the partners and their multiple binding possibilities. These various possibilities suggest networks of interactions at the crowded surface of the cells. Hydrodynamic methods used here proved to be very efficient tools for describing protein-HS complexes that, due to the intrinsic heterogeneity and flexibility of the partners, are otherwise very difficult to analyze.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073444     DOI: 10.1021/bi061490w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  In vitro platform establishes antigen-specific CD8+ T cell cytotoxicity to encapsulated cells via indirect antigen recognition.

Authors:  Ying Li; Anthony W Frei; Ethan Y Yang; Irayme Labrada-Miravet; Chuqiao Sun; Yanan Rong; Magdalena M Samojlik; Allison L Bayer; Cherie L Stabler
Journal:  Biomaterials       Date:  2020-06-15       Impact factor: 12.479

2.  Using prior knowledge in the determination of macromolecular size-distributions by analytical ultracentrifugation.

Authors:  Patrick H Brown; Andrea Balbo; Peter Schuck
Journal:  Biomacromolecules       Date:  2007-05-24       Impact factor: 6.988

3.  Binding Kinetics and Lateral Mobility of HSV-1 on End-Grafted Sulfated Glycosaminoglycans.

Authors:  Nadia Peerboom; Stephan Block; Noomi Altgärde; Olov Wahlsten; Stephanie Möller; Matthias Schnabelrauch; Edward Trybala; Tomas Bergström; Marta Bally
Journal:  Biophys J       Date:  2017-07-08       Impact factor: 4.033

4.  His-FLAG Tag as a Fusion Partner of Glycosylated Human Interferon-Gamma and Its Mutant: Gain or Loss?

Authors:  Elena Krachmarova; Milena Tileva; Elena Lilkova; Peicho Petkov; Klaus Maskos; Nevena Ilieva; Ivan Ivanov; Leandar Litov; Genoveva Nacheva
Journal:  Biomed Res Int       Date:  2017-06-08       Impact factor: 3.411

5.  Heparan Sulfate Facilitates Binding of hIFNγ to Its Cell-Surface Receptor hIFNGR1.

Authors:  Elisaveta Miladinova; Elena Lilkova; Elena Krachmarova; Kristina Malinova; Peicho Petkov; Nevena Ilieva; Genoveva Nacheva; Leandar Litov
Journal:  Int J Mol Sci       Date:  2022-08-20       Impact factor: 6.208

6.  Binding of the chemokine CXCL12α to its natural extracellular matrix ligand heparan sulfate enables myoblast adhesion and facilitates cell motility.

Authors:  Dhruv Thakar; Fabien Dalonneau; Elisa Migliorini; Hugues Lortat-Jacob; Didier Boturyn; Corinne Albiges-Rizo; Liliane Coche-Guerente; Catherine Picart; Ralf P Richter
Journal:  Biomaterials       Date:  2017-01-19       Impact factor: 12.479

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.